Bone marrow failure syndromes

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Philadelphia, PA Saunders 2009
Schriftenreihe:Hematology, oncology clinics of North America 23,2
Schlagworte:
Online-Zugang:Inhaltsverzeichnis
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000 cb4500
001 BV035469651
003 DE-604
005 20090520
007 t|
008 090506s2009 xx ad|| |||| 00||| eng d
020 |a 9781437704877  |9 978-1-4377-0487-7 
020 |a 1437704875  |9 1-4377-0487-5 
035 |a (OCoLC)312626521 
035 |a (DE-599)BVBBV035469651 
040 |a DE-604  |b ger  |e rakwb 
041 0 |a eng 
049 |a DE-19  |a DE-355 
082 0 |a 616.41  |2 22 
084 |a XG 6600  |0 (DE-625)152819:13129  |2 rvk 
084 |a YC 1700  |0 (DE-625)153192:  |2 rvk 
245 1 0 |a Bone marrow failure syndromes  |c guest ed. Grover C. Bagby ... 
264 1 |a Philadelphia, PA  |b Saunders  |c 2009 
300 |a XIV S., S. 159 - 382  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Hematology, oncology clinics of North America  |v 23,2 
650 4 |a Bone Marrow Diseases 
650 4 |a Bone marrow  |x Diseases 
650 0 7 |a Knochenmarkkrankheit  |0 (DE-588)4228476-4  |2 gnd  |9 rswk-swf 
689 0 0 |a Knochenmarkkrankheit  |0 (DE-588)4228476-4  |D s 
689 0 |5 DE-604 
700 1 |a Bagby, Grover C.  |e Sonstige  |0 (DE-588)138119007  |4 oth 
830 0 |a Hematology, oncology clinics of North America  |v 23,2  |w (DE-604)BV000625446  |9 23,2 
856 4 2 |m HBZ Datenaustausch  |q application/pdf  |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017389332&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA  |3 Inhaltsverzeichnis 
943 1 |a oai:aleph.bib-bvb.de:BVB01-017389332 

Datensatz im Suchindex

DE-19_call_number 0760/8 Med.GZ 503(23,2
DE-19_location 55
DE-BY-UBM_katkey 4101384
DE-BY-UBM_media_number 99994918943
DE-BY-UBR_call_number 01/21.X0926
DE-BY-UBR_katkey 4486849
DE-BY-UBR_location 00
DE-BY-UBR_media_number 069036243747
_version_ 1823054321412997120
adam_text Titel: Bone marrow failure syndromes Autor: Bagby, Grover C. Jahr: 2009 Bone Marrow Failure Syndromes Contents Preface xiii Grover C. Bagby and Gabrielle Meyers Global Marrow Failure Dbgnosis and Treatment of Acquired Aplastic Anemia 159 Andrea Bacigalupo and Jakob Passweg Acquired severe aplastic anemia can be treated successfully with either immunosuppressive therapy or bone marrow transplantation. Although immunosuppressive therapy can be readily administered to all patients, it is not a curative approach and is associated with a higher risk of clonal evolution than is transplantation, which yields rapid and long-lasting he- matologic remission. This article reviews the key diagnostic and prognos¬ tic factors that influence the choice of therapy in patients with acquired aplastic anemia. Acquired Aplastic Anemia in Childhood 171 Eva C. Guinan In comparison to past decades, children who have acquired aplastic ane¬ mia (AA) enjoy excellent overall survival that reflects improvements in sup¬ portive care, more accurate exclusion of children who have alternate diagnoses, and advances in transplantation and immunosuppressive ther¬ apy (1ST). Matched sibling-donor hematopoietic stem cell transplants (HSCT) routinely provide long-term survival in the range of 90%, and 75% of patients respond to 1ST. In this latter group, the barriers to overall and complication-free survival include recurrence of AA, clonal evolution with transformation to myelodysplasia/acute myelogenous leukemia, and therapy-related toxicities. Improvements in predicting responses to 1ST, in alternative-donor HSCT, and in rationalizing therapy by understanding the pathophysiology in individual patients are likely to improve short- and long-term outcomes for these children. Fanconi Anemia 193 Allison M. Green and Gary M. Kupfer Fanconi anemia (FA) is an autosomal and X-linked recessive disorder char¬ acterized by bone marrow failure, acute myelogenous leukemia, solid tumors, and developmental abnormalities. Recent years have seen a dra¬ matic improvement in FA patient treatment, resulting in a greater survival of children into adulthood. These improvements have been made despite the fact that a definitive cellular function for the proteins in the FA pathway has yet to be elucidated. Delineating the cellular functions of the FA path¬ way could help further improve the treatment options for FA patients and further reduce the probability of succumbing to the disease. This article Contents reviews the current clinical aspects of FA including presentation, diagno¬ sis, and treatment followed by a review of the molecular aspects of FA as they are currently understood. Dyskeratosis Congenita 215 Sharon A. Savage and Blanche P. Alter Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized clinically by the triad of abnormal nails, reticular skin pigmen¬ tation, and oral leukoplakia, and is associated with high risk of developing aplastic anemia, myelodysplastic syndrome, leukemia, and solid tumors. Patients have very short germline telomeres, and approximately half have mutations in one of six genes encoding proteins that maintain telomere function. Accurate diagnosis of DC is critical to ensure proper clinical man¬ agement, because patients who have DC and bone marrow failure do not respond to immunosuppressive therapy and may have increased morbidity and mortality associated with hematopoietic stem cell transplantation. Shwachman-Diamond Syndrome: A Review of the Clinical Presentation, Molecular Pathogenesis, Diagnosis, and Treatment 233 Lauri Burroughs, Ann Woolfrey, and Akiko Shimamura Shwachman-Diamond syndrome is a rare autosomal-recessive, multisys¬ tem disease characterized by exocrine pancreatic insufficiency, impaired hematopoiesis, and leukemia predisposition. Other clinical features in¬ clude skeletal, immunologic, hepatic, and cardiac disorders. This article focuses on the clinical presentation, diagnostic work-up, clinical manage¬ ment, and treatment of patients with Shwachman-Diamond syndrome. Lineage Restricted Marrow Failure Diagnosis and Management of Acquired Pure Red Cell Aplasia 249 Kenichi Sawada, Makoto Hirokawa, and Naohito Fujishima Pure red cell aplasia is a syndrome characterized by a severe normocytic anemia, reticulocytopenia, and absence of erythroblasts from an other¬ wise normal bone marrow. Although the causes and natural course of this syndrome are variable and although the anemia in some patients can be managed by treatment of an underlying inflammatory or neoplastic disease, the pathogenesis of a large number of cases is autoimmune, in¬ cluding those associated with thymoma, and are best managed with im¬ munosuppressive therapy. Diamond-Blackfan Anemia: Diagnosis,Treatment, and Molecular Pathogenesis 261 Jeffrey M. Upton and Steven R. Ellis Diamond-Blackfan anemia (DBA) is a genetically and clinically heteroge¬ neous disorder characterized by erythroid failure, congenital anomalies, and a predisposition to cancer. Faulty ribosome biogenesis, resulting in proapoptotic erythropoiesis leading to erythroid failure, is hypothesized to Contents be the underlying defect. The genes identified to date that are mutated in DBA all encode ribosomal proteins associated with either the small or large subunit and in these cases haploinsufficiency gives rise to the disease. Ex¬ traordinarily robust laboratory and clinical investigations have recently led to demonstrable improvements in clinical care for patients with DBA. The Congenital Dyserythropoietic Anemias 283 Raffaele Renella and William G. Wood The congenital dyserythropoietic anemias (CDAs) are a heterogeneous group of hereditary disorders that seem to be restricted to the erythroid lin¬ eage. They are characterized by morphologic abnormalities of erythroid precursors in the bone marrow, resulting in ineffective erythropoiesis and a suboptimal reticulocyte response. As with many rare disorders, cases of CDA are often misdiagnosed, which may lead to inappropriate management. In this review, the authors highlight the relevant clinical data together with recent molecular advances that should aid decision making in diagnosis and patient management. Severe Congenital Neutropenia 307 Karl Welte and Cornelia Zeidler Congenital neutropenia (CN) is a genetically heterogeneous bone marrow failure syndrome characterized by a maturation arrest of myelopoiesis at the level of the promyelocyte/myelocyte stage with peripheral blood abso¬ lute neutrophil counts below 0.5 x 109/L From early infancy patients who have CN suffer from bacterial infections. Leukemias occur in both the autosomal dominant and recessive subtypes of CN. The individual risk for each genetic subtype needs to be evaluated further, because the number of patients tested for the underlying genetic defect is still limited. Acquired G-CSFR (CSF3R) mutations are detected in approximately 80% of pa¬ tients who had CN and who developed acute myeloid leukemia, suggest¬ ing that these mutations are involved in leukemogenesis. Congenital Amegakeryocytic Thrombocytopenia and Thrombocytopenia with Absent Radii 321 Amy E. Geddis Thrombocytopenia in the neonate usually is acquired but in rare cases may be caused by a congenital disorder. This article summarizes the diagnosis, pathophysiology, and management of two congenital inherited platelet disorders that present in the newborn period: congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. Marrow Failure and Evolution of Neoplastic Clones Bone Marrow Failure Syndromes: Paroxysmal Nocturnal Hemoglobinuria 333 Charles J. Parker This article discusses the etiology of paroxysmal nocturnal hemoglobinuria (PNH) and its relationship to marrow hyperplasia. The author posits that Contents the defining clinical pathology of PNH (ie, complementmediated intra- vascular hemolysis) is an epiphenomenon that is a consequence of an orchestrated response (ie, natural selection of PIGA-mulant stem cells) to a specific type of bone marrow injury (ie, immune mediated). Manage¬ ment of PNH is discussed also. Hypocellular Myelodysplasia 347 Elaine M. Sloand Myelodysplasia must be considered in the differential diagnosis of patients who have bone marrow failure, but bone marrow cellularity per se may not substantially affect either response to therapy or prognosis. It is unclear whether the primary pathophysiologic defect differs between hyper- and hypoplastic patients who have myelodysplasia. Cellularity does not seem to affect response to immunosuppressive therapy significantly and does not seem to be the major factor affecting improvements in response to lenalidomide, stem cell transplantation, or hematopoietic growth factors. Melodysplasia and Acute Leukemia as Late Complications of Marrow Failure: Future Prospects for Leukemia Prevention 361 Grover C. Bagby and Gabrielle Meyers Patients who have acquired and inherited bone marrow failure syndromes are at risk for the development of clonal neoplasms including acute myeloid leukemia, myelodysplastic syndrome, and paroxysmal nocturnal hemoglobinuria. This article reviews the evidence supporting a model of clonal selection, a paradigm that provides a reasonable expectation that these often fatal complications might be prevented in the future. Index 377
any_adam_object 1
author_GND (DE-588)138119007
building Verbundindex
bvnumber BV035469651
classification_rvk XG 6600
YC 1700
ctrlnum (OCoLC)312626521
(DE-599)BVBBV035469651
dewey-full 616.41
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 616 - Diseases
dewey-raw 616.41
dewey-search 616.41
dewey-sort 3616.41
dewey-tens 610 - Medicine and health
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01569nam a2200397 cb4500</leader><controlfield tag="001">BV035469651</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090520 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">090506s2009 xx ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781437704877</subfield><subfield code="9">978-1-4377-0487-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1437704875</subfield><subfield code="9">1-4377-0487-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)312626521</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035469651</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.41</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XG 6600</subfield><subfield code="0">(DE-625)152819:13129</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 1700</subfield><subfield code="0">(DE-625)153192:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bone marrow failure syndromes</subfield><subfield code="c">guest ed. Grover C. Bagby ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia, PA</subfield><subfield code="b">Saunders</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV S., S. 159 - 382</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Hematology, oncology clinics of North America</subfield><subfield code="v">23,2</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bone Marrow Diseases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bone marrow</subfield><subfield code="x">Diseases</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Knochenmarkkrankheit</subfield><subfield code="0">(DE-588)4228476-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Knochenmarkkrankheit</subfield><subfield code="0">(DE-588)4228476-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bagby, Grover C.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)138119007</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Hematology, oncology clinics of North America</subfield><subfield code="v">23,2</subfield><subfield code="w">(DE-604)BV000625446</subfield><subfield code="9">23,2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&amp;doc_library=BVB01&amp;local_base=BVB01&amp;doc_number=017389332&amp;sequence=000002&amp;line_number=0001&amp;func_code=DB_RECORDS&amp;service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017389332</subfield></datafield></record></collection>
id DE-604.BV035469651
illustrated Illustrated
indexdate 2025-02-03T17:28:01Z
institution BVB
isbn 9781437704877
1437704875
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-017389332
oclc_num 312626521
open_access_boolean
owner DE-19
DE-BY-UBM
DE-355
DE-BY-UBR
owner_facet DE-19
DE-BY-UBM
DE-355
DE-BY-UBR
physical XIV S., S. 159 - 382 Ill., graph. Darst.
publishDate 2009
publishDateSearch 2009
publishDateSort 2009
publisher Saunders
record_format marc
series Hematology, oncology clinics of North America
series2 Hematology, oncology clinics of North America
spellingShingle Bone marrow failure syndromes
Hematology, oncology clinics of North America
Bone Marrow Diseases
Bone marrow Diseases
Knochenmarkkrankheit (DE-588)4228476-4 gnd
subject_GND (DE-588)4228476-4
title Bone marrow failure syndromes
title_auth Bone marrow failure syndromes
title_exact_search Bone marrow failure syndromes
title_full Bone marrow failure syndromes guest ed. Grover C. Bagby ...
title_fullStr Bone marrow failure syndromes guest ed. Grover C. Bagby ...
title_full_unstemmed Bone marrow failure syndromes guest ed. Grover C. Bagby ...
title_short Bone marrow failure syndromes
title_sort bone marrow failure syndromes
topic Bone Marrow Diseases
Bone marrow Diseases
Knochenmarkkrankheit (DE-588)4228476-4 gnd
topic_facet Bone Marrow Diseases
Bone marrow Diseases
Knochenmarkkrankheit
url http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017389332&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA
volume_link (DE-604)BV000625446
work_keys_str_mv AT bagbygroverc bonemarrowfailuresyndromes